Observational study shows significant reduction in nephrotoxicity risks and enhances workflow in radiology, indicating better patient outcomes.
Background: Disruptions in radiology scheduling frequently stem from complications associated with contrast media, most notably nephrotoxicity and hypersensitivity reactions. Integrating a clinical pharmacist into this environment has emerged as a viable strategy to streamline procedures and strengthen patient safety. Objective: This investigation sought to quantify the influence of pharmacist integration on operational efficiency and clinical outcomes in the imaging department of a tertiary Saudi hospital. Methods: In a prospective observational design, adult patients scheduled for contrast-enhanced studies were enrolled. The pharmacist conducted risk assessments, oversees premedication, and orchestrates nephroprotection measures. Workflow metrics and adverse event rates were analyzed before and after the intervention. Results: The median interval from registration to completion fell from 8.4 hours to 5.2 hours. Cancellations linked to contrast precautions declined from 12.5% to 4.3%. Rates of contrast-induced nephropathy and allergic events dropped by more than 60%. Ninety-three distinct interventions were documented, underscoring the pharmacists contribution to safety and efficiency. Conclusion: Embedding a pharmacist in radiology markedly acceleres workflow and reduces harm. These results advocate for structured interprofessional collaboration as a blueprint for refining diagnostic services in tertiary centers.
No takes yet. Share an insight, caveat, or question.
Alkhamis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: